Gangolli Julian S

Outlook Therapeutics, Inc. · Director

Gangolli Julian S is listed in public filings as director. This Gangolli Julian S insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Outlook Therapeutics, Inc. (OTLK), Krystal Biotech, Inc. (KRYS), and Revance Therapeutics, Inc. - Common Stock (RVNC). Investors use Gangolli Julian S's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Outlook Therapeutics, Inc.OTLK$298k286.7k sharesGrant / ExerciseOct 1, 2025$298.2K286.7k shares$1.04--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Krystal Biotech, Inc.KRYS$687k5k sharesGrant / ExerciseJun 30, 2025$687.3K5k shares$137.46--
Revance Therapeutics, Inc. - Common StockRVNC--15k sharesOtherFeb 6, 2025Disclosure amount unavailable15k shares----
Revance Therapeutics, Inc. - Common StockRVNC$55k15k sharesOtherFeb 4, 2025$109.9K30.1k shares$3.65--
Outlook Therapeutics, Inc.OTLK$372k71.2k sharesGrant / ExerciseOct 1, 2024$371.5K71.2k shares$5.22--
Outlook Therapeutics, Inc.OTLK$296k56.6k sharesGrant / ExerciseOct 1, 2024$295.6K56.6k shares$5.22--